Highlights
NASDAQ: SGNL       Signal Genetics Cmn
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

Avg Volume (4 weeks):0
52 Weeks Range:0.12 - 17.74
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

miRagen Therapeutics Inc., formerly Signal Genetics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of micro-ribonucleic acid (RNA)-targeted therapies. Its lead product candidates, MRG-106 and MRG-201, are in Phase I clinical trials. Its therapeutic areas of focus include cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Its clinical product candidate for the treatment of certain cancers, MRG-106, is an inhibitor of microRNA-155, which is found at abnormally high levels in several blood cancers. The Company's clinical product candidate for the treatment of pathological fibrosis, MRG-201, is a replacement for miR-29, which is found at abnormally low levels in a range of pathological fibrotic conditions, including cardiac, renal, hepatic and pulmonary fibrosis, as well as systemic sclerosis. In addition to its clinical programs, it is developing a pipeline of pre-clinical product candidates.

  Be the first to like this.
 


 

4720  2281  573  751 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CSQ 11.43+0.02 
 BNCL 16.95+0.35 
 GALT 3.129-0.141 
 BBRY 9.190.00 
 NUGT 7.765-0.405 
 X 23.297-7.813 
 TWTR 15.981+1.321 
 BAC 24.13+0.15 
 SPY 239.34+0.79 
 EEM 40.08-0.12 
Partners & Brokers